Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary

Related Experiment Video

Updated: May 19, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Jian Wei Zhang1, Yu Jie Zhou, Qing Yang

  • 1Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.

Angiology
|September 4, 2012
PubMed

Insights

Patients with chronic obstructive pulmonary disease (COPD) undergoing percutaneous coronary intervention (PCI) face higher risks of adverse cardiac events and longer hospital stays. COPD severity further exacerbates these negative outcomes after PCI.

Area of Science:

  • Cardiology
  • Pulmonology
  • Clinical Outcomes

Background:

  • Chronic obstructive pulmonary disease (COPD) is prevalent in patients with coronary heart disease undergoing percutaneous coronary intervention (PCI).
  • Limited research exists on the impact of COPD on post-PCI outcomes.

Purpose of the Study:

  • To investigate the association between COPD and in-hospital outcomes following PCI.
  • To evaluate the effect of COPD severity on major adverse cardiac events (MACE) and hospital stay after PCI.

Main Methods:

  • A consecutive cohort of 5155 patients with coronary heart disease undergoing PCI was analyzed.
  • Patients were stratified into groups with and without COPD (n=645 vs. n=4510).
  • In-hospital outcomes including angina, arrhythmias, composite MACE, and hospital stay were compared. COPD severity was assessed using pulmonary function tests.

Main Results:

  • Patients with COPD had significantly higher rates of angina, arrhythmias, and composite MACE compared to those without COPD (P < .001).
  • COPD patients experienced significantly longer hospital stays post-PCI (P < .001).
  • Increased COPD severity correlated with higher composite MACE and prolonged hospital stay (P < .001).

Conclusions:

  • COPD is independently associated with increased in-hospital MACE and longer hospital stay in patients undergoing PCI.
  • The severity of COPD is a significant predictor of adverse outcomes and extended hospitalization after PCI.
  • These findings highlight the importance of considering COPD in risk stratification and management of cardiac patients undergoing PCI.

Keywords:
chronic obstructive pulmonary diseasehospital staymajor adverse cardiac eventspercutaneous coronary interventionpulmonary function test

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...